Lineage Cell Therapeutics In shares owned by Raffles Associates
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Raffles Associates
from 13F filings
Historical chart of Raffles Associates investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Raffles Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Raffles Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $9.1M | 5.4M | 1.69 |
| 2025-06-30 | $4.9M | 5.4M | 0.91 |
| 2025-03-31 | $2.5M | 5.6M | 0.45 |
| 2024-12-31 | $2.8M | 5.5M | 0.50 |
| 2024-09-30 | $4.1M | 4.5M | 0.91 |
| 2024-06-30 | $4.3M | 4.4M | 1.00 |
| 2024-03-31 | $4.8M | 3.2M | 1.48 |
| 2023-12-31 | $2.3M | 2.1M | 1.09 |
| 2023-09-30 | $1.9M | 1.6M | 1.18 |
| 2023-06-30 | $2.3M | 1.6M | 1.41 |
| 2023-03-31 | $2.3M | 1.5M | 1.50 |
| 2022-12-31 | $1.8M | 1.5M | 1.17 |
| 2022-09-30 | $2.4M | 2.1M | 1.13 |
| 2022-06-30 | $3.1M | 1.9M | 1.58 |
| 2022-03-31 | $2.0M | 1.3M | 1.54 |
| 2021-12-31 | $1.3M | 544k | 2.45 |
| 2021-09-30 | $236k | 94k | 2.52 |
| 2021-06-30 | $124k | 44k | 2.84 |
| 2021-03-31 | $102k | 44k | 2.34 |